Dr. Barsyte-Lovejoy is an Assistant Professor at the Department of Pharmacology and Toxicology and Principal Investigator at the Structural Genomics Consortium. She received a PhD in molecular biology from the University of Manchester, UK and postdoctoral training at the Ontario Cancer Institute. Dr. Barsyte-Lovejoy’s research focuses on understanding how epigenetic regulators control cell survival, death, and adaptation. Epigenetic enzymes that methylate lysine/arginine residues on histones, transcription, splicing or repair factors, chaperones, and signaling proteins provide additional levels of functional regulation profoundly impacting the biological systems. Using the chemical probe, small molecule compounds that modulate epigenetic regulators we are investigating the cellular functions of these proteins and their potential to become therapeutic targets in diseases such as cancer.
Dalia Barsyte-Lovejoy MSc, PhD
Principal Investigator, Structural Genomics Consortium
T: (416) 946-3867
University of Toronto, Structural Genomics Consortium
101 College St MaRS St tw 712
Toronto, ON, M5G1L7
epigenetics, protein methylation, transcription and chromatin regulation, stress response, chemical biology, cancer therapeutics